Embla Medical hf (LTS:0FIW) ROCE % : 9.30% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Embla Medical hf's annualized ROCE % for the quarter that ended in Dec. 2024 was 9.30%.

Embla Medical hf ROCE % Historical Data

The historical data trend for Embla Medical hf's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf ROCE % Chart

Embla Medical hf Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

2.12

9.40

6.47

8.14

9.21

Embla Medical hf Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															9.91	5.44	10.05	10.08	9.30

Embla Medical hf ROCE % Calculation

Embla Medical hf's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	810.573	/	( ( (9470.859 - 1340.974)	+	(10960.663 - 1490.542) )	/ 2 )
	=	810.573	/	( (8129.885	+	9470.121)	/ 2 )
	=	810.573	/	8800.003
	=	9.21 %

Embla Medical hf's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	871.916	/	( ( (10631.282 - 1354.174)	+	(10960.663 - 1490.542) )	/ 2 )
	=	871.916	/	( ( 9277.108	+	9470.121 )	/ 2 )
	=	871.916	/	9373.6145
	=	9.30 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Embla Medical hf (LTS:0FIW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Embla Medical hf ROCE % Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (LTS:0FIW) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

OSSFF:USA EMBLA:Denmark

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.emblamedical.com

Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

No Headlines